Literature DB >> 21837529

Volume of excision and cosmesis with routine cavity shave margins technique.

Julie Mook1, Rebecca Klein, Anne Kobbermann, Alison Unzeitig, David Euhus, Yan Peng, Venetia Sarode, Amy Moldrem, A Marilyn Leitch, Valerie Andrews, Sumeet Teotia, Roshni Rao.   

Abstract

BACKGROUND: Cavity shave margin (CSM) removal is a surgical technique that reduces re-excision rates. One criticism of this technique has been that negative margins are obtained primarily as a result of higher volumes of tissue removed. This study evaluates the volume of tissue removed in a group that underwent CSM versus one that underwent standard partial mastectomy (SPM) and explores cosmetic outcomes.
METHODS: Single-institution retrospective review identified 533 patients with a diagnosis of breast cancer who underwent PM. Matched pair analysis of 72 patients who had undergone PM with CSM versus 72 who had undergone SPM was performed. Volumes were calculated from dimensions in the pathology report. A subgroup was analyzed by a multidisciplinary panel for cosmetic outcome using the Harvard Breast Cosmesis Grading Scale.
RESULTS: Mean tumor size in the CSM group was 1.52 versus 1.51 cm(3) in the SPM (P = 0.8073). Mean total volume of tissue excised with CSM was lower than that in the SPM group. Mean volume of excision with CSM was 80.66 and 165.1 cm(3) in the SPM group (P = 0.0005). Patients undergoing CSM required fewer re-excisions than the SPM group: 13 (18.1%) versus 25 (34.6%) (P = 0.03). Mean score for cosmesis was 2.3 in the CSM group and 3.0 for SPM (P = 0.0004).
CONCLUSIONS: CSM decreases the need for re-excision. Total tissue volume excised is lower in patients who undergo CSM, and cosmetic results appear to be improved. This approach should be considered for all patients undergoing PM.

Entities:  

Mesh:

Year:  2011        PMID: 21837529     DOI: 10.1245/s10434-011-1982-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  9 in total

1.  Effect of Surgeon Factors on Long-Term Patient-Reported Outcomes After Breast-Conserving Therapy in Older Breast Cancer Survivors.

Authors:  Benjamin D Smith; Xiudong Lei; Kevin Diao; Ying Xu; Yu Shen; Grace L Smith; Sharon H Giordano; Sarah M DeSnyder; Kelly K Hunt; Mediget Teshome; Reshma Jagsi; Simona F Shaitelman; Susan K Peterson; Cameron W Swanick
Journal:  Ann Surg Oncol       Date:  2020-01-08       Impact factor: 5.344

2.  A Randomized, Controlled Trial of Cavity Shave Margins in Breast Cancer.

Authors:  Anees B Chagpar; Brigid K Killelea; Theodore N Tsangaris; Meghan Butler; Karen Stavris; Fangyong Li; Xiaopan Yao; Veerle Bossuyt; Malini Harigopal; Donald R Lannin; Lajos Pusztai; Nina R Horowitz
Journal:  N Engl J Med       Date:  2015-05-30       Impact factor: 91.245

3.  The Evolution of Axillary Staging in Breast Cancer.

Authors:  Roshni Rao
Journal:  Mo Med       Date:  2015 Sep-Oct

Review 4.  Preoperative localization and surgical margins in conservative breast surgery.

Authors:  F Corsi; L Sorrentino; D Bossi; A Sartani; D Foschi
Journal:  Int J Surg Oncol       Date:  2013-08-05

5.  [Conservative treatment of breast cancer: experience of a Tunisian team].

Authors:  Kaouther Dimassi; Anissa Gharsa; Mohammed Badis Chanoufi; Ezzeddine Sfar; Dalenda Chelli
Journal:  Pan Afr Med J       Date:  2014-10-15

Review 6.  Cavity Shaving plus Lumpectomy versus Lumpectomy Alone for Patients with Breast Cancer Undergoing Breast-Conserving Surgery: A Systematic Review and Meta-Analysis.

Authors:  Ke Wang; Yu Ren; Jianjun He
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

Review 7.  Novel techniques for intraoperative assessment of margin involvement.

Authors:  Dorin Dumitru; Michael Douek; John R Benson
Journal:  Ecancermedicalscience       Date:  2018-01-10

8.  Toolbox to Reduce Lumpectomy Reoperations and Improve Cosmetic Outcome in Breast Cancer Patients: The American Society of Breast Surgeons Consensus Conference.

Authors:  Jeffrey Landercasper; Deanna Attai; Dunya Atisha; Peter Beitsch; Linda Bosserman; Judy Boughey; Jodi Carter; Stephen Edge; Sheldon Feldman; Joshua Froman; Caprice Greenberg; Cary Kaufman; Monica Morrow; Barbara Pockaj; Melvin Silverstein; Lawrence Solin; Alicia Staley; Frank Vicini; Lee Wilke; Wei Yang; Hiram Cody
Journal:  Ann Surg Oncol       Date:  2015-07-28       Impact factor: 5.344

9.  A randomized prospective study of lumpectomy margin assessment with use of MarginProbe in patients with nonpalpable breast malignancies.

Authors:  Freya Schnabel; Susan K Boolbol; Mark Gittleman; Tami Karni; Lorraine Tafra; Sheldon Feldman; Alice Police; Neil B Friedman; Scott Karlan; Dennis Holmes; Shawna C Willey; Moshe Carmon; Kristen Fernandez; Stephanie Akbari; Jay Harness; Lisa Guerra; Thomas Frazier; Karen Lane; Rache M Simmons; Alison Estabrook; Tanir Allweis
Journal:  Ann Surg Oncol       Date:  2014-03-05       Impact factor: 5.344

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.